Anti-ERBB1/EGFR/HER1 Antibody (Modotuximab)
Catalog No.
F1516
Anti-ERBB1/EGFR/HER1 Antibody (Modotuximab)
Featured Products
Modotuximab (Anti-Human EGFR Recombinant Antibody) is an IgG1κ chimeric antibody targeting human EGFR protein. Modotuximab contains Futuximab part, which can bind to two independent non-overlapping epitopes on EGFR. Modotuximab promotes the cross-linking of EGFR on the cell surface, promotes EGFR cell internalization and degradation. Modotuximab has anti-tumor activity in vivo.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.6 kDa
Dry ice
1310460-86-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
DS 1024, Zatuximab, DS-1024, Modotuximab (USAN/INN)
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00533
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
ERBB1 / EGFR / HER1
Please avoid freeze-thaw cycles.